Cel AI looks to refocus as it business is 'right-sized' – Proactive Investors USA

Pharma & Biotech
Sustainability
Cannabis
Battery Metals
Artificial Intelligence
Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive’s editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually. Prior to Proactive, Ian helped lead the business output at the Daily… Read more
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.
Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.
We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.
The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.
Proactive has always been a forward looking and enthusiastic technology adopter.
Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.
Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.
Proactive Investors Australia Pty Ltd ACN 132 787 654 (the Company, we or us) provides you with access to the content set out above, including any news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) and this website (the Site) on the terms set out in this disclaimer, together with all other terms and conditions, disclaimers and other notices displayed elsewhere on this Site. It is important for you to know that: (a) none of the Content is, or is intended to be, general or personal advice (b) the principal purpose of the Content is to provide factual information only and to comment on news; (c) the Content does not contain or imply any recommendation or opinion intended to influence your financial decisions, including in respect of any particular security, portfolio of securities, transaction or…
Published: 03:03 28 May 2024 EDT
Cel AI PLC’s (LSE:CLAI) new management said it has successfully ‘right-sized’ the business as it refocused investment on its AI tool, which helps customers make the best skincare decisions.
“We see this as a great opportunity for growth, allowing us to leverage our expertise in the wellness industry more effectively and lucratively,” the company said in a statement accompanying its interim.
“To further engage and expand our customer base, we have initiated a social media campaign.
“This campaign aims to raise brand awareness, showcase our products’ benefits, and foster community engagement. We are now working to upgrade and optimise our campaign in this space to enhance its reach and impact.”
As part of the strategic overhaul under new CEO Mike Edwards, the monthly cash burn has dropped from £150,000 to £50,000 extending the runway significantly. At the end of February, Cel AI had £1 million in the bank.
As would be expected of a business at the early stages of its commercial journey, Cel AI was lossmaking. The deficit for the six months ending February 29 was £626,819, down from £1.8 million a year earlier.
 
 
 
Sign up to receive alerts and news direct to your inbox
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) CEO Simon Morriss is back with Proactive after the company launched an assessment to aid in the detection of two types of cancer. The genomic-based biotech has launched a comprehensive risk assessment test, targeting all women at…
Copyright © Proactive Group Holdings Inc, 2024
All Rights Reserved – Proactive North America Inc., Proactive Investors LLC.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.

source